MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2021-22)
- Udyam number
- UDYAM-MH-23-0034320
Future Generic Private Limited
Future Generic Private Limited - pharma in Nashik, Maharashtra, India. Directors, charges & compliance details.
Revenue · FY 2024
₹31.51 Lakh
▼ 47% YoY
Net loss · FY 2024
₹3,425
Net margin -0.1%
EBITDA · FY 2024
-₹3,425
EBITDA margin -0.1%
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
5 yrs
Est. 2021
Directors on board
3
As per MCA filings
Last financials
Mar 2025
Balance sheet date
About Future Generic Private Limited
Data last updated:
Future Generic Private Limited is a private limited company based in Nashik, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 25 March 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24290MH2021PTC357885.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Bharat Sudhakar Birari and Ishwarchandra Devidas Bhamare.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Flat No. 301 Garden View App.Pl No 47 S. No. 866/2A Near Saptashrungi Mandir, Nashik, Maharashtra, India – 422006.
As per the financials filed for FY 2024, the company reported a revenue of ₹31.51 Lakh, a decline of 47% compared to the previous year. For the same year it recorded a net loss of ₹3,425 (net margin -0.1%) and EBITDA of -₹3,425 (EBITDA margin -0.1%).
Future Generic Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-23-0034320).
Company details
CIN U24290MH2021PTC357885
Registration Number 357885
Incorporation Date 25 March 2021
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-MH-23-0034320
Key People
Bharat Sudhakar Birari Director Ishwarchandra Devidas Bhamare Director Manoj Ambadas Birari Director Recognitions & Rankings of Future Generic
Contact details
Future Generic Private Limited's registered office is in Nashik, Maharashtra.
- Registered AddressFlat No. 301 Garden View App.Pl No 47 S. No. 866/2A Near Saptashrungi Mandir, Nashik, Maharashtra, India – 422006
- IndustryPharma, Drug Formulation & Development
Comprehensive company report
Future Generic Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Financials of Future Generic Private Limited
FY 2025 filings availableFuture Generic Private Limited reported revenue of ₹31.51 Lakh (down 47% YoY) for FY 2024.
Revenue · FY 2024
₹31.51 Lakh ▼ 47%
Net loss · FY 2024
₹3,425 margin -0.1%
EBITDA · FY 2024
-₹3,425 margin -0.1%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 47%
EBITDA CAGR growth
1 year
▲ 99%
Revenue fell 47% in the latest year. EBITDA rose 99% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | -₹3,425 | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | -₹3,425 | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | -0.1% | |||
| Net Profit Margin | -0.1% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Future Generic Private Limited, buy the company report.
Board of directors of Future Generic Private Limited
Future Generic has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Bharat Sudhakar Birari | Director | 25 Mar 2021 | 5 Years 7 Months | Current |
| Ishwarchandra Devidas Bhamare | Director | 25 Mar 2021 | 5 Years 7 Months | Current |
| Manoj Ambadas Birari Also directs: Genericare Medicine Private Limited, Genericare Pharmacy Private Limited, 3Biz Healthcare Private Limited and 1 more | Director | 25 Mar 2021 | 5 Years 7 Months | Current |
Legal cases
No court or tribunal cases involving Future Generic Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Future Generic Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Future Generic Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Future Generic Private Limited has 7 board changes on record since 2021: 5 appointments and 2 cessations. The latest: Jagdeep Singh ceased to be Director on 03 May 2023.
AGM
Future Generic Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Future Generic Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai Ii.
Ceased
Jagdeep Singh ceased to be Director.
Ceased
Supreet Singh ceased to be Director.
Appointed
Bharat Sudhakar Birari was appointed as Director.
Appointed
Ishwarchandra Devidas Bhamare was appointed as Director.
Appointed
Jagdeep Singh was appointed as Director.
Appointed
Manoj Ambadas Birari was appointed as Director.
Appointed
Supreet Singh was appointed as Director.
Incorporation
25 Mar 2021
Future Generic Private Limited was registered on 25 Mar 2021 with Roc Mumbai Ii & aged 5 years 7 months as per MCA records.
Frequently asked questions
Future Generic is an active private limited company based in Nashik, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 25 March 2021 (5+ years old) and is registered under CIN U24290MH2021PTC357885.
Future Generic has 3 current directors:
- Bharat Sudhakar Birari - Director
- Ishwarchandra Devidas Bhamare - Director
- Manoj Ambadas Birari - Director
The latest financial statements of Future Generic on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The CIN (Corporate Identification Number) of Future Generic is U24290MH2021PTC357885. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Future Generic was incorporated on 25 March 2021, making it 5+ years old. It is registered with the Registrar of Companies, Mumbai.
Jagdeep Singh ceased to be Director on 03 May 2023. Supreet Singh ceased to be Director on 03 May 2023. Bharat Sudhakar Birari was appointed as Director on 25 Mar 2021. Future Generic has 7 board changes on record in total.
Yes, Future Generic is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-23-0034320).
The registered office of Future Generic is at Flat No. 301 Garden View App.Pl No 47 S. No. 8662A Near Saptashrungi Mandir, Nashik, Maharashtra, India – 422006.
Future Generic operates in the pharma industry, in the drug formulation and development segment.
Future Generic can be reached at its registered office: Flat No. 301 Garden View App.Pl No 47 S. No. 8662A Near Saptashrungi Mandir, Nashik, Maharashtra, India – 422006.